Decitabine [clinicaltrials_resource:1290239b74bf72b7aef921f67bdca29d]
clinicaltrials:NCT00002831clinicaltrials:NCT00002832Decitabine in Treating Patients With Melanoma or Other Advanced Cancer [clinicaltrials:NCT00002980]Decitabine in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003361]Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura [clinicaltrials:NCT00019825]Decitabine in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00030615]clinicaltrials:NCT00037817Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec) [clinicaltrials:NCT00041990]Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec) [clinicaltrials:NCT00042003]Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec) [clinicaltrials:NCT00042016]Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [clinicaltrials:NCT00042796]Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00043134]Decitabine Versus Supportive Care in Adults With Advanced-stage MDS [clinicaltrials:NCT00043381]Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia [clinicaltrials:NCT00049582]Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00054431]clinicaltrials:NCT00067808clinicaltrials:NCT00075010Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma [clinicaltrials:NCT00075634]Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [clinicaltrials:NCT00079378]Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer [clinicaltrials:NCT00084981]clinicaltrials:NCT00085293Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas [clinicaltrials:NCT00089089]clinicaltrials:NCT00095784Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00109824]clinicaltrials:NCT00113321clinicaltrials:NCT00114257clinicaltrials:NCT00260065clinicaltrials:NCT00260832Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia [clinicaltrials:NCT00275080]A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00282399]clinicaltrials:NCT00321711clinicaltrials:NCT00349596Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases [clinicaltrials:NCT00357708]clinicaltrials:NCT00358644clinicaltrials:NCT00382200clinicaltrials:NCT00398983clinicaltrials:NCT00414310clinicaltrials:NCT00416598clinicaltrials:NCT00477386clinicaltrials:NCT00479232
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Decitabine [clinicaltrials_resource:1290239b74bf72b7aef921f67bdca29d]
Bio2RDF identifier
1290239b74bf72b7aef921f67bdca29d
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1290239b74bf72b7aef921f67bdca29d
identifier
clinicaltrials_resource:1290239b74bf72b7aef921f67bdca29d
title
Decitabine
@en
type
label
Decitabine [clinicaltrials_resource:1290239b74bf72b7aef921f67bdca29d]
@en